￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Relapse rate after treatment with ruxolitinib/ruxolitinib cream

2026-02-01 22:25:32

Check Details
How effective is niraparibabiraterone tablets in prostate cancer?

2026-02-01 22:25:32

Check Details
When was Enactuzumab launched in China?

2026-02-01 22:25:32

Check Details
Comparison of efficacy and side effects of Etrasimod

2026-02-01 22:25:32

Check Details
Has the FDA approved the use of niraparib and abiraterone tablets?

2026-02-01 22:25:32

Check Details
How effective is eractuzumab in the treatment of multiple myeloma?

2026-02-01 22:25:32

Check Details
The efficacy and mechanism of action of tocilizumab

2026-02-01 22:25:32

Check Details
Is there a generic version of Etrasimod? Version comparison

2026-02-01 22:25:32

Check Details
How should Niraparibabiraterone tablets be stored?

2026-02-01 22:25:32

Check Details
What is the main target of eractuzumab?

2026-02-01 22:25:32

Check Details
Detailed explanation of precautions for use of tocilizumab

2026-02-01 22:25:32

Check Details
The Difference Between Etrasimod and Mesalazine

2026-02-01 22:25:32

Check Details
Category
相关知识